Rheal A Towner1, Nataliya Smith2, Debra Saunders2, Samuel B Van Gordon3, Amy B Wisniewski3, Karl R Tyler4, Beverley Greenwood-Van Meerveld4, Robert E Hurst3. 1. Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: Rheal-Towner@omrf.org. 2. Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma. 3. Department of Urology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma. 4. Department of Physiology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Abstract
PURPOSE: Interstitial cystitis/painful bladder syndrome is a devastating disease associated with multiple symptoms. It is usually diagnosed based on pain, urgency and frequency in the absence of other known causes. To our knowledge there is no diagnostic test to date. MATERIALS AND METHODS: In a model of rats intravesically exposed to protamine sulfate we performed in vivo diagnostic contrast enhanced magnetic resonance imaging with intravesical administration of Gd-diethylenetriamine pentaacetic acid contrast medium via a catheter to visualize increased bladder urothelium permeability. Gd-diethylenetriamine pentaacetic acid was administered intravenously to visualize secondary tissue effects in the colon. RESULTS: Bladder urothelium and colon mucosa were assessed 24 hours after bladder protamine sulfate exposure. Enhanced contrast magnetic resonance imaging established bladder urothelium leakage of Gd-diethylenetriamine pentaacetic acid according to the change in magnetic resonance imaging signal intensity in rats exposed to protamine sulfate vs controls (mean ± SD 399.7% ± 68.7% vs 39.2% ± 12.2%, p < 0.0001) as well as colon related uptake of contrast agent (mean 65.2% ± 17.1% vs 20.8% ± 9.8%, p < 0.01) after bladder protamine sulfate exposure. The kinetics of Gd-diethylenetriamine pentaacetic acid uptake and excretion were also assessed during 20 minutes of bladder and 30 minutes of colon exposure with increased signal intensity at 7 and 12 minutes, respectively. CONCLUSIONS: These preliminary studies indicate that contrast enhanced magnetic resonance imaging can be used to monitor primary bladder urothelium loss of permeability and secondary enhanced contrast medium in the colon mucosa. It can be considered a potential clinical diagnostic method for interstitial cystitis/painful bladder syndrome that involves loss of the permeability barrier. It can also be used to assess visceral organ cross talk.
PURPOSE:Interstitial cystitis/painful bladder syndrome is a devastating disease associated with multiple symptoms. It is usually diagnosed based on pain, urgency and frequency in the absence of other known causes. To our knowledge there is no diagnostic test to date. MATERIALS AND METHODS: In a model of rats intravesically exposed to protamine sulfate we performed in vivo diagnostic contrast enhanced magnetic resonance imaging with intravesical administration of Gd-diethylenetriamine pentaacetic acid contrast medium via a catheter to visualize increased bladder urothelium permeability. Gd-diethylenetriamine pentaacetic acid was administered intravenously to visualize secondary tissue effects in the colon. RESULTS: Bladder urothelium and colon mucosa were assessed 24 hours after bladder protamine sulfate exposure. Enhanced contrast magnetic resonance imaging established bladder urothelium leakage of Gd-diethylenetriamine pentaacetic acid according to the change in magnetic resonance imaging signal intensity in rats exposed to protamine sulfate vs controls (mean ± SD 399.7% ± 68.7% vs 39.2% ± 12.2%, p < 0.0001) as well as colon related uptake of contrast agent (mean 65.2% ± 17.1% vs 20.8% ± 9.8%, p < 0.01) after bladder protamine sulfate exposure. The kinetics of Gd-diethylenetriamine pentaacetic acid uptake and excretion were also assessed during 20 minutes of bladder and 30 minutes of colon exposure with increased signal intensity at 7 and 12 minutes, respectively. CONCLUSIONS: These preliminary studies indicate that contrast enhanced magnetic resonance imaging can be used to monitor primary bladder urothelium loss of permeability and secondary enhanced contrast medium in the colon mucosa. It can be considered a potential clinical diagnostic method for interstitial cystitis/painful bladder syndrome that involves loss of the permeability barrier. It can also be used to assess visceral organ cross talk.
Authors: Katia Monastyrskaya; Verónica Sánchez-Freire; Ali Hashemi Gheinani; David J Klumpp; Eduard B Babiychuk; Annette Draeger; Fiona C Burkhard Journal: Am J Pathol Date: 2012-11-29 Impact factor: 4.307
Authors: Jocelyn J Fitzgerald; Elena Ustinova; Kevin B Koronowski; William C de Groat; Michael A Pezzone Journal: Auton Neurosci Date: 2012-11-24 Impact factor: 3.145
Authors: Robert E Hurst; Samuel Van Gordon; Karl Tyler; Bradley Kropp; Rheal Towner; HsuehKung Lin; John O Marentette; Jane McHowat; Ehsan Mohammedi; Beverley Greenwood-Van Meerveld Journal: Am J Physiol Renal Physiol Date: 2016-02-24
Authors: Pradeep Tyagi; Joseph J Janicki; T Kevin Hitchens; Lesley M Foley; Mahendra Kashyap; Naoki Yoshimura; Jonathan Kaufman Journal: Am J Physiol Renal Physiol Date: 2017-03-29
Authors: Beverley Greenwood-Van Meerveld; Ehsan Mohammadi; Karl Tyler; Samuel Van Gordon; Alex Parker; Rheal Towner; Robert Hurst Journal: J Urol Date: 2015-03-14 Impact factor: 7.450
Authors: Rheal A Towner; Amy B Wisniewski; Dee H Wu; Samuel B Van Gordon; Nataliya Smith; Justin C North; Rayburt McElhaney; Christopher E Aston; S Abbas Shobeiri; Bradley P Kropp; Beverley Greenwood-Van Meerveld; Robert E Hurst Journal: J Urol Date: 2015-08-22 Impact factor: 7.450
Authors: R A Towner; N Smith; D Saunders; S B Van Gordon; K R Tyler; A B Wisniewski; B Greenwood-Van Meerveld; R E Hurst Journal: Neurogastroenterol Motil Date: 2015-08-24 Impact factor: 3.598
Authors: Rheal A Towner; Nataliya Smith; Debra Saunders; Megan Lerner; Beverley Greenwood-Van Meerveld; Robert E Hurst Journal: Am J Nucl Med Mol Imaging Date: 2020-02-25
Authors: Robert E Hurst; Beverley Greenwood-Van Meerveld; Amy B Wisniewski; Samuel VanGordon; HsuehKung Lin; Bradley P Kropp; Rheal A Towner Journal: Transl Androl Urol Date: 2015-10
Authors: Pradeep Tyagi; Chan-Hong Moon; Joseph Janicki; Jonathan Kaufman; Michael Chancellor; Naoki Yoshimura; Christopher Chermansky Journal: F1000Res Date: 2018-11-09
Authors: Sara Dinis; Joana Tavares de Oliveira; Rui Pinto; Francisco Cruz; Ca Tony Buffington; Paulo Dinis Journal: Int J Womens Health Date: 2015-07-23